FDA approves trial for CBD-based drug to treat opioid addiction
The U.S. Food & Drug Administration (FDA) said a CBD-based treatment for opioid use disorder can be used in clinical trials, Ananda Scientific Inc., the drug’s maker, announced this week. […]
FDA approves trial for CBD-based drug to treat opioid addiction Read More »